Exciting evidence for first all-oral treatment for relapsed and treatment-resistant multiple myeloma

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Immunotherapy makes patients’ tumours "melt away"

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia

Tosedostat for elderly acute myeloid leukaemia

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma

Daratumumab for multiple myeloma

Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients